Why it matters: Years of pandemic disruption have caused students to struggle with stress management, problem solving and peer relationships, the survey found.
CVS Health is getting into the biosimilars business, launching a subsidiary called Cordavis that will initially work with the manufacturer Sandoz to produce a low-cost version of the blockbuster arthritis drug Humira.
Why it matters: CVS already sources generic drugs in a partnership with Cardinal Health and is pursuing a bigger footprint in a biosimilars market that's expected to be worth $100 billion by the end of this decade.
After a year of scrutinizing fraud in the hospice industry, Medicare dropped the hammer this week: The agency warned nearly 400 hospices are at risk of being bounced from the program if they can't prove they're a legitimate enterprise.
Why it matters: The move to root out fraudulent hospices, following years of reports about shady practices in the industry, signals that federal officials are aiming to crack down on unscrupulous actors cashing in on Medicare's $22 billion per year end-of-life care program.
The nationwide median rate of kindergartners with vaccine exemptions nearly doubled between the school years ending in 2012 and 2022, per CDC estimates.
The big picture: While COVID-19 vaccination is not required for young children attending public school anywhere in the U.S., it appears that concerns over that shot may be fueling broader vaccine skepticism among a relatively small but growing number of parents — though that trend certainly existed before the pandemic.
A total of 22 states have moved to ban or restrict abortion following the Supreme Court's decision to overturn Roe v. Wade and end all federal protections for abortion.
Why it matters: At least 24 U.S. states in total are expected to ban abortions or heavily restrict access to them, according to the Guttmacher Institute, an abortion-rights organization.
South Carolina's Supreme Court on Wednesday upheld a ban on abortions after six weeks of pregnancy.
Why it matters: The decision, made by the state's all-male justices, marks a reversal for the court after it struck down an abortion ban earlier this year.
As the U.S. battles rising maternal death rates, 1 in 5 mothers say they were verbally abused, ignored or otherwise disrespected by health care providersduring maternal care, according to a new government survey.
Why it matters: Ensuring that patients are treated respectfully during pregnancy, childbirth and the postpartum period is key to reducing pregnancy-related deaths, said the Centers for Disease Control and Prevention, which published the survey.
Facing a tight labor market and rising health care costs, employers are wrestling with how to afford a new wave of pricey, highly effective treatments without forcing workers to bear too much of the cost.
Why it matters: From emerging gene and cell-based therapies in cancer and other conditions to a buzzy class of weight-loss drugs, the landscape for game-changing treatments has never been quite so promising — or expensive for employers.
The Biden administration's new biomedical research agency is providing $24 million for research leveraging an mRNA platform to train the immune system to fight cancer and other diseases, officials told Axios first.
Why it matters: The project, led by Emory University in Atlanta, supports the administration's "cancer moonshot" — part of President Biden's "unity agenda"— aimed at cutting the cancer death rate in half over 25 years.
